George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

13 Jun 2012 07:00

RNS Number : 2299F
Sopheon PLC
13 June 2012
 



SOPHEON PLC

 

AGM Statement

 

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

 

"After strong growth in 2010, we reported 2011 revenues broadly similar to the prior year at £10.3m. EBITDA of £1.5m was also essentially the same as 2010, and in line with market expectations. Thanks to strict control of costs and enhanced conversion of development work into standard products, we achieved these results despite the expansion of staff in sales, services and development. For the second year in a row, we are also pleased to report a positive bottom-line profit after tax of £104,000.

 

Last year was characterized by strong demand from our client base for extension business, which absorbed the attention of our sales team. One consequence was that sales efforts were less focused on generating completely new accounts. We have now reorganized our sales resources to drive more balanced attention to both new account acquisition and generating additional growth out of our client base. We have already seen an improvement in new client acquisition compared to last year. We believe this will be reflected in improved license performance in 2012. In early 2011, we grew staff levels in key areas. These levels were maintained until recently, when increased demand led us to make further controlled expansion of staff. In particular, we advanced our market presence across Europe with the addition of two sales representatives. We also added technical resources across the business in response to growing service requirements. These hires were made with due caution given that global markets have not yet regained their poise.

 

During 2011, we introduced a new agile development methodology which has improved our ability to build products faster, and do a better job of ensuring that they are in step with real customer needs. A major product milestone was achieved with the release of Accolade 8.0, offering enhanced support for project portfolio management and collaboration, integration with Microsoft's SharePoint® and a mobile application for use with iPhone® and iPad® devices. We have also collaborated with Kalypso, the global innovation consulting firm and Sopheon partner, to introduce a new offering called FEI OptimizerTM that will help consumer goods manufacturers increase the value of new products by improving ideation and concept development.

 

On the corporate front, we successfully extended the maturity of the group's £850,000 convertible loan by two years to January 2015, coupled with a modification of the conversion price to 5p. In addition, we are today requesting shareholders to approve the transfer of Sopheon's listing from NYSE Euronext in Amsterdam to NYSE Alternext, an exciting market that is a better match for our corporate profile. This change is also subject to regulatory approval.

 

Full year 2012 revenue visibility from contracted business and recurring revenue streams has now risen to £7.5 million compared to £6.5 million announced on 3 May, and £6.6 million at the time of our AGM statement a year ago. We expect this to translate into higher reported first-half revenues than in 2011. In addition, we are working to close a substantial amount of business in the remaining weeks of June. Accurate prediction of the timing and value of sales events remains difficult, but if closed this month, the new business would further boost first-half performance." 

 

Sopheon's annual report and accounts for the year ended 31 December 2011 has been provided to shareholders and is available from the Company's website www.sopheon.com.

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte StrannerHenrik PerssonVictoria Bates

finnCap

+ 44 (0) 20 7600 1658

Guy McDougallHeather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BAE Systems, BASF, Corning, Electrolux, Honeywell, Novartis and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

 

Revenue visibility is defined in Note4 of Sopheon's 2011 annual report which is available from the investor section of www.sopheon.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFLRRTIFLIF
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.